Topias Lemetyinen, Senior Epidemiologist, GlobalData, explains why HCV continues to be an enduring...
- Expert Insights: Moderna Therapeutics Barrels Ahead Towards Historic IPO
- Industry Viewpoints: Leveraging eSource in Data Management
- The Fundamentals Behind Effective Data Management
- We Need to Talk About Race: Lack of Diversity in Clinical Trials is a Public Health Issue
- Sample Tracking Automation: Do I Have Your Consent?
Industry Viewpoints: The Challenges of Clinical Data Management
In this Industry Viewpoint, Sarah Fal speaks to Kumar Komuravelli, Mallinckrodt Pharmaceuticals, on the arising technologies taking over the industry
Expert Insights: Moderna Therapeutics Barrels Ahead Towards Historic IPO
Paul Jeng, PhD, Infectious Diseases Analyst, GlobalData, analyzes Moderna Therapeutics’ growing stature as the young biotech punches above its weight
Industry Viewpoints: Leveraging eSource in Data Management
CTA’s Sarah Fal interviews Terry Katz, Merck Animal Health, on the latest clinical data management trends and challenges
Enriched Evidence Generation: Linking Clinical Data, Registries and Patient-Reported Outcomes to Health Care Utilization
Eric Van Ganse, Manon Belhassen, PELyon, & Francois Gavini, Roche, explain how French national claims data can deliver critical value to clinical trials and patients registries
Expert Insights: Another Failure for BACE1 Drugs Raises Questions about Alzheimer’s Disease Treatments
Alessio Brunello, MSc, Neurology & Ophthalmology Analyst, GlobalData, explores the implications of Janssen’s decision to halt its Alzheimer’s disease clinical trial
Expert Insights: Can FDA Approval of Cimzia for Psoriasis Secure UCB’s Position in the Immuno-dermatology Market?
Vikesh Devlia, MSc, Immunology Analyst, GlobalData, examines the implications of the FDA’s recent approval of UCB’s Cimzia drug